Long-term prognostic value of ctDNA in early breast cancer: insights from the neoadjuvant ABCSG-34 Trial.
- DOI
- 10.1038/s41523-026-00934-z
- Published
- 2026 Apr 8
- Container
- NPJ breast cancer
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41523-026-00934-z,
title = {Long-term prognostic value of ctDNA in early breast cancer: insights from the neoadjuvant ABCSG-34 Trial.},
author = {Egle D and Hlauschek D and Gampenrieder SP and Rinnerthaler G and Singer C and Pfeiler G and Bartsch R and Huber G and Pichler A and Petru E and Bago-Horvath Z and Kermanidis AS and Fesl C and Zhou Q and Graf R and Hammer S and Dandachi N and Filipits M and Gnant M and Heitzer E and Balic M},
year = {2026},
journal = {NPJ breast cancer},
doi = {10.1038/s41523-026-00934-z},
url = {https://doi.org/10.1038/s41523-026-00934-z}
}RIS
TY - JOUR TI - Long-term prognostic value of ctDNA in early breast cancer: insights from the neoadjuvant ABCSG-34 Trial. AU - Egle D AU - Hlauschek D AU - Gampenrieder SP AU - Rinnerthaler G AU - Singer C AU - Pfeiler G AU - Bartsch R AU - Huber G AU - Pichler A AU - Petru E AU - Bago-Horvath Z AU - Kermanidis AS AU - Fesl C AU - Zhou Q AU - Graf R AU - Hammer S AU - Dandachi N AU - Filipits M AU - Gnant M AU - Heitzer E AU - Balic M PY - 2026 JO - NPJ breast cancer DO - 10.1038/s41523-026-00934-z UR - https://doi.org/10.1038/s41523-026-00934-z ER -
APA
D, E., D, H., SP, G., G, R., C, S., G, P., R, B., G, H., A, P., E, P., Z, B., AS, K., C, F., Q, Z., R, G., S, H., N, D., M, F., M, G., E, H., & M, B. (2026). Long-term prognostic value of ctDNA in early breast cancer: insights from the neoadjuvant ABCSG-34 Trial.. NPJ breast cancer. https://doi.org/10.1038/s41523-026-00934-z
Source records
- pubmed · retrieved 2026-09-26T21:24:48.142Z